|
MTMR1
|
myotubularin related protein 1 |
- Synthesis of PIPs at the plasma membrane
- RHOF GTPase cycle
|
|
|
|
MTMR10
|
myotubularin related protein 10 |
- Synthesis of PIPs at the early endosome membrane
|
|
|
|
MTMR2
|
myotubularin related protein 2 |
- Synthesis of PIPs at the ER membrane
- Synthesis of PIPs at the plasma membrane
- Synthesis of PIPs at the early endosome membrane
- Synthesis of PIPs at the early endosome membrane
- Synthesis of PIPs at the late endosome membrane
|
|
- Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
|
|
MTMR6
|
myotubularin related protein 6 |
- Synthesis of PIPs at the plasma membrane
|
|
|
|
MTMR8
|
myotubularin related protein 8 |
- Synthesis of PIPs at the plasma membrane
|
|
|
|
MTMR9
|
myotubularin related protein 9 |
- Synthesis of PIPs at the plasma membrane
- Synthesis of PIPs at the late endosome membrane
- Synthesis of IP2, IP, and Ins in the cytosol
|
|
|
|
MUC1
|
mucin 1, cell surface associated |
- Defective GALNT3 causes HFTC
- Defective C1GALT1C1 causes TNPS
- Defective GALNT12 causes CRCS1
- Dectin-2 family
- Interleukin-4 and Interleukin-13 signaling
- O-linked glycosylation of mucins
- Termination of O-glycan biosynthesis
- Developmental Lineage of Mammary Gland Luminal Epithelial Cells
- Developmental Lineage of Mammary Gland Alveolar Cells
|
|
|
|
MUC4
|
mucin 4, cell surface associated |
- Defective GALNT3 causes HFTC
- Defective C1GALT1C1 causes TNPS
- Defective GALNT12 causes CRCS1
- Dectin-2 family
- O-linked glycosylation of mucins
- Termination of O-glycan biosynthesis
|
|
|
|
MYCBP
|
MYC binding protein |
|
|
|
|
MYCBP2
|
MYC binding protein 2 |
|
|
|
|
NCK1
|
NCK adaptor protein 1 |
- Downstream signal transduction
- Generation of second messenger molecules
- Regulation of actin dynamics for phagocytic cup formation
- Regulation of actin dynamics for phagocytic cup formation
- Nephrin family interactions
- DCC mediated attractive signaling
- DCC mediated attractive signaling
- Activation of RAC1
- VEGFA-VEGFR2 Pathway
- RHO GTPases Activate WASPs and WAVEs
- RHO GTPases Activate WASPs and WAVEs
- RHOU GTPase cycle
- RHOV GTPase cycle
- FCGR3A-mediated phagocytosis
- FCGR3A-mediated phagocytosis
- Potential therapeutics for SARS
- PKR-mediated signaling
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
|
|
|
NCK2
|
NCK adaptor protein 2 |
- Downstream signal transduction
- Nephrin family interactions
- Ephrin signaling
- Activation of RAC1
- VEGFA-VEGFR2 Pathway
- Regulation of cortical dendrite branching
- RHOU GTPase cycle
- RHOV GTPase cycle
|
|
|
|
NDUFAB1
|
NADH:ubiquinone oxidoreductase subunit AB1 |
- Respiratory electron transport
- Complex I biogenesis
- Mitochondrial Fatty Acid Beta-Oxidation
- Protein lipoylation
- Mitochondrial ribosome-associated quality control
|
|
|
|
NEDD4
|
NEDD4 E3 ubiquitin protein ligase |
- ISG15 antiviral mechanism
- Downregulation of ERBB4 signaling
- Regulation of PTEN localization
- Regulation of PTEN stability and activity
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
|
NRG1
|
neuregulin 1 |
- Signaling by ERBB2
- Signaling by ERBB4
- SHC1 events in ERBB2 signaling
- SHC1 events in ERBB2 signaling
- PI3K events in ERBB4 signaling
- SHC1 events in ERBB4 signaling
- Nuclear signaling by ERBB4
- PIP3 activates AKT signaling
- GRB7 events in ERBB2 signaling
- Downregulation of ERBB2:ERBB3 signaling
- GRB2 events in ERBB2 signaling
- PI3K events in ERBB2 signaling
- Constitutive Signaling by Aberrant PI3K in Cancer
- RAF/MAP kinase cascade
- ERBB2 Regulates Cell Motility
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- ERBB2 Activates PTK6 Signaling
- Downregulation of ERBB2 signaling
- Long-term potentiation
- Signaling by ERBB2 KD Mutants
- Signaling by ERBB2 TMD/JMD mutants
|
|
|
|
NRG2
|
neuregulin 2 |
- Signaling by ERBB2
- Signaling by ERBB4
- Signaling by ERBB4
- SHC1 events in ERBB2 signaling
- SHC1 events in ERBB2 signaling
- PI3K events in ERBB4 signaling
- SHC1 events in ERBB4 signaling
- Nuclear signaling by ERBB4
- PIP3 activates AKT signaling
- GRB7 events in ERBB2 signaling
- Downregulation of ERBB2:ERBB3 signaling
- GRB2 events in ERBB2 signaling
- PI3K events in ERBB2 signaling
- Constitutive Signaling by Aberrant PI3K in Cancer
- RAF/MAP kinase cascade
- ERBB2 Regulates Cell Motility
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- ERBB2 Activates PTK6 Signaling
- Downregulation of ERBB2 signaling
- Signaling by ERBB2 KD Mutants
- Signaling by ERBB2 TMD/JMD mutants
|
|
|
|
NSMCE1
|
NSE1 component of SMC5/6 complex |
- SUMOylation of DNA damage response and repair proteins
|
|
|
|
ODF2L
|
outer dense fiber of sperm tails 2 like |
|
|
|
|
PA2G4
|
proliferation-associated 2G4 |
|
|
|
|
PDGFRA
|
platelet derived growth factor receptor alpha |
- PIP3 activates AKT signaling
- Downstream signal transduction
- Signaling by PDGF
- Constitutive Signaling by Aberrant PI3K in Cancer
- RAF/MAP kinase cascade
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
- Signaling by PDGFRA extracellular domain mutants
- Imatinib-resistant PDGFR mutants
- Sunitinib-resistant PDGFR mutants
- Regorafenib-resistant PDGFR mutants
- Sorafenib-resistant PDGFR mutants
- PDGFR mutants bind TKIs
|
- Becaplermin
- Imatinib
- Sunitinib
- XL820
- Olaratumab
- Pazopanib
- Midostaurin
- Regorafenib
- Ponatinib
- Lenvatinib
- Nintedanib
- Foreskin keratinocyte (neonatal)
- Tivozanib
- Fostamatinib
- Erdafitinib
- Amuvatinib
- Ripretinib
|
|